Literature DB >> 8513871

A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection.

E F Rappaport1, D L Cassel, D O Walterhouse, S E McKenzie, S Surrey, M A Keller, A D Schreiber, E Schwartz.   

Abstract

The Fc gamma receptors (Fc gamma R) are glycoproteins that bind the Fc region of immunoglobulin G. Human hematopoietic cells express three biochemically distinct classes of Fc gamma receptors: Fc gamma RI (CD64), Fc gamma RII (CD32) and Fc gamma RIII (CD16). Complementary DNA (cDNA) clones for each of the human Fc gamma receptors have been isolated from myeloid and lymphoid cells. We describe the isolation and characterization of four Fc gamma RII clones from a cDNA library obtained from a megakaryocyte-like cell line, human erythroleukemia (HEL). Three clones encode the Fc gamma RIIA transmembrane (TM) form, while one novel clone lacks the TM region but retains the cytoplasmic domain. By conducting reverse transcription coupled to polymerase chain reaction (PCR), we found transcripts coding for this unique form of receptor in RNA from platelets, HEL cells and a second megakaryocyte-like cell line, CHRF-288-11. These results were confirmed by RNase protection analysis of RNA from HEL cells. The structure of the novel cDNA suggested that it codes for a soluble form of Fc gamma RIIA. A soluble Fc gamma RII protein was detected in the conditioned medium from HEL cells but not from the Fc gamma RII-negative T cell line, Jurkat, by immunoprecipitation with the anti-Fc gamma RII monoclonal antibody (mAb), IV.3. The immunoprecipitated protein was of the expected size for a soluble Fc gamma RII lacking the TM region but retaining the cytoplasmic domain. Soluble Fc gamma RIIA may be important in modulating the interaction between immune complexes and membrane-associated Fc gamma RII.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513871

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  9 in total

1.  Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Authors:  Xinrui Li; Jianming Wu; Travis Ptacek; David T Redden; Elizabeth E Brown; Graciela S Alarcón; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Richard A Kaslow; Robert P Kimberly; Jeffrey C Edberg
Journal:  Sci Transl Med       Date:  2013-12-18       Impact factor: 17.956

2.  Lineage-specific alternative splicing of the human Fc gamma RIIA transmembrane exon requires sequences near the 3' splice site.

Authors:  M A Keller; S E McKenzie; D L Cassel; E F Rappaport; E Schwartz; S Surrey
Journal:  Gene Expr       Date:  1995

3.  Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism.

Authors:  A F Reilly; C F Norris; S Surrey; F J Bruchak; E F Rappaport; E Schwartz; S E McKenzie
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

4.  Variation in human FCGR2C gene copy number.

Authors:  A F Reilly; S Surrey; E F Rappaport; E Schwartz; S E McKenzie
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults.

Authors:  K D Fairchild; R G Hudson; S D Douglas; S E McKenzie; R A Polin
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

6.  Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution.

Authors:  P Sondermann; R Huber; U Jacob
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

Review 7.  Targeting the Fc receptor in autoimmune disease.

Authors:  Xinrui Li; Robert P Kimberly
Journal:  Expert Opin Ther Targets       Date:  2014-03       Impact factor: 6.902

Review 8.  The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.

Authors:  Peter Sondermann
Journal:  J Clin Immunol       Date:  2016-04-02       Impact factor: 8.317

Review 9.  Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

Authors:  Carlos Rosales
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.